Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Study of Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal at a Large Tertiary Care Medical Center

NCT03064035 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT03064035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03064035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Study of Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal at a Large Tertiary Care Medical Center
Lead sponsor
HealthPartners Institute
Phase
Phase 4
Overall status
Completed
Start date
April 5, 2017
Completion date
April 24, 2019
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute bleeding on long-term anticoagulation therapy, hemorrhage, significant bleeding in patients with a coagulopathy (prolonged thrombin time), urgent reversal of vitamin k antagonist (vka) anticoagulation